Trends in the incidence, prevalence and sales volume of menopausal hormone therapy in Sweden from 2000 to 2021

Vasomotor symptoms, such as hot flushes and nocturnal sweats, are experienced by 60 –80 % of all European women at some point during the menopausal transition [1]. The most effective treatment to reduce vasomotor symptoms is menopausal hormone therapy (MHT) [2], also referred to as hormone replacement therapy (HRT).
Source: Maturitas - Category: Primary Care Authors: Tags: Original article Source Type: research